Cambridge, MA USA
Add to Favorites | Newsroom RSS | Share

Our News on Newswise

Brexit Could Threaten Neurodegenerative Disease Research in Europe

Neurodegenerative disease researchers in the U.K. fear the Brexit will curtail their access to EU funds and complicate international collaborations. Analysts agree that a U.K. exit is likely to harm big science across the continent.
11-Jul-2016 12:05 PM EDT Add to Favorites

Fresh Insights Into Sleep, Brain Cleansing, and Memory

Researchers are making progress in understanding exactly how sleep helps the brain lay down memories and remove waste products. The findings may have implications for diseases in which sleep and memory are impaired. Alzforum reports.
23-May-2016 5:05 PM EDT Add to Favorites

Drug Trials in Frontotemporal Dementia: Can Industry, Academia, Families and Regulators Get on One Page?

In Washington, D.C., stakeholders in frontotemporal dementia came together to apply lessons learned from setbacks of Alzheimer’s drug development to the emerging field of therapy evaluation in FTD.
26-Apr-2016 1:05 PM EDT Add to Favorites

NIH Summit Sets Priorities for Research on the Non-Alzheimer’s Dementias

Last month, scientists gathered to powwow about where we are with FTD, DLB, and cerebrovascular disorders and how best to target research dollars to them. Researchers articulated funding priorities for each of these diseases, which will inform the...
21-Apr-2016 1:05 PM EDT Add to Favorites

Coming MOOC Opens Learning on Lesser-Known Dementia Variants to All

A free, open online course on rare forms of dementia aims to spread knowledge while harnessing social learning.
18-Feb-2016 4:05 PM EST Add to Favorites

Cancer Drug Benefit for Alzheimer’s Disease Looks Questionable

Studies report no reduction in the amyloid-β peptide or the plaques it forms. Hints of efficacy came from four people free of the ApoE4 risk gene for AD, and one patient who was on it for nearly two years. Meanwhile, scientists uncovered a new...
15-Feb-2016 11:05 AM EST Add to Favorites

ROCK’N the Tau? Vasospasm Drug Shows Promise in Models of Dementia

Inhibiting the Rho kinases ROCK1 and ROCK2 with fasudil, a drug approved in China and Japan, stimulates tau autophagy in cell culture and flies.
9-Feb-2016 11:05 AM EST Add to Favorites

Will Death in French Drug Trial Lead to Tighter Phase 1 Rules?

While regulators are trying to figure out what went wrong, independent chemists have dug into the mechanism of what may have been a "dirty" drug.
1-Feb-2016 10:05 AM EST Add to Favorites

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos

Youtube feed not yet configured. Is this your Newswise member page? Contact to configure this module.